Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis 06/18/2023 INTERVENTIONAL unchanged 1,165.85 0 Sleep Disordered Breathing, Endothelial Function, and Adverse Events in Pregnancy 06/18/2023 OBSERVATIONAL unchanged 1,165.85 0 Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes 06/18/2023 OBSERVATIONAL unchanged 1,165.85 0 A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE 06/18/2023 INTERVENTIONAL unchanged 1,165.85 0 MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos Therapy: Feasibility Study 06/18/2023 INTERVENTIONAL unchanged 1,165.85 0 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) 06/18/2023 INTERVENTIONAL unchanged 1,165.85 0 Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy 06/18/2023 OBSERVATIONAL unchanged 1,165.85 0 Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin 06/18/2023 INTERVENTIONAL unchanged 1,165.85 0 A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer 06/18/2023 INTERVENTIONAL unchanged 1,165.85 0 A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 Ultrahypofractionation and Normal Tissue Toxicity 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 Development and Management of Registry in Patients With Gynecologic Cancer in Korea 06/22/2023 OBSERVATIONAL unchanged 1,161.85 0 Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 HIIT Following Breast Cancer Chemotherapy 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery 06/22/2023 OBSERVATIONAL unchanged 1,161.85 0 Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI) 06/22/2023 INTERVENTIONAL unchanged 1,161.85 0 Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer 06/22/2023 OBSERVATIONAL unchanged 1,161.85 0 Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies 06/22/2023 OBSERVATIONAL unchanged 1,161.85 0 Breastfeeding Failure: Influence of Smartphone Use and Distraction Factors 06/23/2023 OBSERVATIONAL unchanged 1,160.85 0 [18F]FES PET/.CT in Uterine Cancer 06/23/2023 INTERVENTIONAL unchanged 1,160.85 0 Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study 06/23/2023 OBSERVATIONAL unchanged 1,160.85 0 Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes 06/26/2023 INTERVENTIONAL unchanged 1,157.85 0 Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC 06/26/2023 INTERVENTIONAL unchanged 1,157.85 0 Effects of rTMS on Food Choice in Anorexia Nervosa 06/26/2023 INTERVENTIONAL unchanged 1,157.85 0 Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial 06/27/2023 INTERVENTIONAL unchanged 1,156.85 0 Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer 06/27/2023 INTERVENTIONAL unchanged 1,156.85 0 The Impact of Innovative Technology Strategies on Implementing Exercise Programs Using Fully Immersive Virtual Reality for Postpartum Women 06/27/2023 INTERVENTIONAL unchanged 1,156.85 0 A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device 06/28/2023 OBSERVATIONAL unchanged 1,155.85 0 Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. 06/28/2023 INTERVENTIONAL unchanged 1,155.85 0 Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? 06/28/2023 OBSERVATIONAL unchanged 1,155.85 0 Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France 06/29/2023 OBSERVATIONAL unchanged 1,154.85 0 Group Preconception Care for Fertility Patients 06/29/2023 INTERVENTIONAL unchanged 1,154.85 0 Aspirin for Postpartum Patients With Preeclampsia 06/29/2023 INTERVENTIONAL unchanged 1,154.85 0 Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment 07/03/2023 OBSERVATIONAL unchanged 1,150.85 0 Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial 07/03/2023 INTERVENTIONAL unchanged 1,150.85 0 Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer 07/03/2023 INTERVENTIONAL unchanged 1,150.85 0 Digital Data Linkage and Scheduling to Track Pregnancy With or Without Community Data Use to Increase Antenatal Clinic Uptake in Western Kenya. 07/03/2023 INTERVENTIONAL unchanged 1,150.85 0 Iron Deficiency Anemia (IDA) and the Brain 07/03/2023 INTERVENTIONAL unchanged 1,150.85 0 Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial 07/05/2023 INTERVENTIONAL unchanged 1,148.85 0 Certolizumab in Recurrent Implantation Failure (RIF) 07/05/2023 INTERVENTIONAL unchanged 1,148.85 0 Cortisol, Hippocampus, and Insula in Anorexia Nervosa. 07/05/2023 OBSERVATIONAL unchanged 1,148.85 0 Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors 07/05/2023 INTERVENTIONAL unchanged 1,148.85 0 AK104 for Recurrent or Metastatic Vulvar Cancer 07/06/2023 INTERVENTIONAL unchanged 1,147.85 0 Neurophysiologic Biomarkers in Rett Syndrome 07/06/2023 OBSERVATIONAL unchanged 1,147.85 0 Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention 07/06/2023 INTERVENTIONAL unchanged 1,147.85 0 Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor 07/06/2023 INTERVENTIONAL unchanged 1,147.85 0 Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer 07/06/2023 OBSERVATIONAL unchanged 1,147.85 0 Culturally Adapted Strong Families Programme for Families Living in Gilgit Baltistan, Pakistan 07/06/2023 INTERVENTIONAL unchanged 1,147.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology